1. Home
  2. NEO vs AORT Comparison

NEO vs AORT Comparison

Compare NEO & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$9.16

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Artivion Inc.

AORT

Artivion Inc.

HOLD

Current Price

$22.82

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEO
AORT
Founded
2001
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2008
1996

Fundamental Metrics

Financial Performance
Metric
NEO
AORT
Price
$9.16
$22.82
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
5
Target Price
$13.38
$49.40
AVG Volume (30 Days)
2.0M
753.0K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
165.62
EPS
N/A
0.03
Revenue
N/A
$298,836,000.00
Revenue This Year
$10.63
$14.20
Revenue Next Year
$9.73
$11.20
P/E Ratio
N/A
$751.00
Revenue Growth
N/A
18.01
52 Week Low
$4.72
$19.16
52 Week High
$13.74
$48.25

Technical Indicators

Market Signals
Indicator
NEO
AORT
Relative Strength Index (RSI) 58.70 24.78
Support Level $7.42 $19.16
Resistance Level $10.82 $38.43
Average True Range (ATR) 0.40 1.85
MACD 0.03 -0.48
Stochastic Oscillator 78.90 19.80

Price Performance

Historical Comparison
NEO
AORT

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

Share on Social Networks: